Clinical course of non-severe aplastic anemia in adults

International Journal of Hematology

Volumn 91, Issue 5, 2010, Pages 770-775

  Kwon, Ji Hyun ^a   Kim, Inho ^a,b   Lee, Yun Gyoo ^a   Koh, Youngil ^a   Park, Hayne Cho ^a   Song, Eun Young ^b   Kim, Hyun Kyung ^b   Yoon, Sung Soo ^a,b   Lee, Dong Soon ^b   Park, Sung Sup ^b   Shin, Hee Young ^b   Park, Seonyang ^a,b   Park, Myoung Hee ^b   Ahn, Hyo Seop ^b   Kim, Byoung Kook ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Clinical course; Non severe aplastic anemia; Prognosis; Treatment responsiveness

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HEMOGLOBIN; OXYMETHOLONE; THYMOCYTE ANTIBODY; ANDROGEN; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CYTOPENIA; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL COUNT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PROGNOSIS; PROGRESSION FREE SURVIVAL; SOUTH KOREA; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT RESPONSE; ANEMIA, APLASTIC; KOREA; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANDROGENS; ANEMIA, APLASTIC; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KOREA; MALE; MIDDLE AGED; OXYMETHOLONE; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77954535505     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0601-1     Document Type: Article

References (21)

1. JC Marsh SE Ball P Darbyshire EC Gordon-Smith AJ Keidan A Martin, et al. 2003 Guidelines for the diagnosis, management of acquired aplastic anaemia Br J Haematol 123 5 782 801 10.1046/j.1365-2141.2003.04721.x 1:STN:280: DC%2BD3srpsFCrtA%3D%3D 14632769 (Pubitemid 37533290)
2. R Storb W Leisenring C Anasetti FR Appelbaum CD Buckner WI Bensinger, et al. 1997 Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin Blood 89 10 3890 3891 1:CAS:528:DyaK2sXjtlSnsbY%3D 9160700
3. JR Passweg G Socie W Hinterberger A Bacigalupo JC Biggs BM Camitta, et al. 1997 Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 90 2 858 864 1:CAS:528:DyaK2sXksF2jtLs%3D 9226187
4. L Ades JY Mary M Robin C Ferry R Porcher H Esperou, et al. 2004 Long-term outcome after bone marrow transplantation for severe aplastic anemia Blood 103 7 2490 2497 10.1182/blood-2003-07-2546 1:CAS:528:DC%2BD2cXjtValu7s%3D 14656884 (Pubitemid 38392998)
5. A Bacigalupo B Bruno P Saracco E Di Bona A Locasciulli F Locatelli, et al. 2000 Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO) Blood 95 6 1931 1934 1:CAS:528:DC%2BD3cXhvVGgs74%3D 10706857
6. S Rosenfeld D Follmann O Nunez NS Young 2003 Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome JAMA 289 9 1130 1135 10.1001/jama.289.9.1130 1:CAS:528:DC%2BD3sXhvVOisL4%3D 12622583 (Pubitemid 37430327)
7. SC Howard PE Naidu XJ Hu MR Jeng C Rodriguez-Galindo MD Rieman, et al. 2004 Natural history of moderate aplastic anemia in children Pediatr Blood Cancer 43 5 545 551 10.1002/pbc.20131 15382271 (Pubitemid 39313953)
8. S Kojima S Nakao M Tomonaga J Hows J Marsh S Gerard, et al. 2000 Consensus conference on the treatment of aplastic anemia Int J Hematol 72 1 118 123 1:STN:280:DC%2BD3cvpt1GhsQ%3D%3D 10979223
9. R Champlin W Ho RP Gale 1983 Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial N Engl J Med 308 3 113 118 1:STN:280:DyaL3s%2FovVOrsQ%3D%3D 6336819
10. BM Camitta ED Thomas DG Nathan G Santos EC Gordon-Smith RP Gale, et al. 1976 Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality Blood 48 1 63 70 1:STN:280: DyaE283jt1Kqug%3D%3D 779871
11. RL Paquette N Tebyani M Frane P Ireland WG Ho RE Champlin, et al. 1995 Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation Blood 85 1 283 290 1:CAS:528:DyaK2MXivFakur0%3D 7803802
12. JP Maciejewski EM Sloand O Nunez C Boss NS Young 2003 Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia Blood 102 10 3584 3586 10.1182/blood-2003-04-1032 1:CAS:528:DC%2BD3sXptVymtrY%3D 12881307 (Pubitemid 37409374)
13. Koh Y, Lee HR, Song EY, Kim HK, Kim IH, Yoon SS, et al. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA). Blood (ASH Annual Meeting Abstracts) 2009;114(Abstract):3199.
14. J Marsh H Schrezenmeier P Marin O Ilhan P Ljungman S McCann, et al. 1999 Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party Blood 93 7 2191 2195 1:CAS:528:DyaK1MXit1KhsLY%3D 10090926
15. JC Marsh JM Hows KA Bryett S Al-Hashimi SM Fairhead EC Gordon-Smith 1987 Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity Blood 70 4 1046 1052 1:STN:280:DyaL1c%2FgtV2rtg%3D%3D 3651599
16. MJ Ahn JH Choi YY Lee IY Choi IS Kim SS Yoon, et al. 2003 Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial Int J Hematol 78 2 133 138 10.1007/BF02983381 12953807
17. N Nishio H Yagasaki Y Takahashi H Muramatsu A Hama N Yoshida, et al. 2009 Natural history of transfusion-independent non-severe aplastic anemia in children Int J Hematol 89 4 409 413 10.1007/s12185-009-0302-9 19343478
18. XH Qiao XT Xie SY Jiang W Shi W Li JJ Zhou 2008 Natural history of moderate aplastic anemia in children and effects of immunosuppressive therapy Zhonghua Er Ke Za Zhi 46 12 909 913 19134253
19. SY Kao W Xu JM Brandwein JH Lipton HA Messner MD Minden, et al. 2008 Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy Br J Haematol 143 5 738 743 10.1111/j.1365-2141.2008.07389.x 19062343
20. A Tichelli G Socie M Henry-Amar J Marsh J Passweg H Schrezenmeier, et al. 1999 Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party Ann Intern Med 130 3 193 201 1:STN:280: DyaK1M7kvF2rsA%3D%3D 10049197
21. P Scheinberg CO Wu O Nunez NS Young 2009 Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia Br J Haematol 144 2 206 216 10.1111/j.1365-2141.2008.07450.x 1:CAS:528:DC%2BD1MXit1CnsLw%3D 19036108